Comparative effectiveness of erenumab versus rimegepant for migraine prevention using matching-adjusted indirect comparison
Aim: To compare the efficacy of erenumab versus rimegepant as preventive treatment for patients with episodic and chronic migraine using an anchor-based matching-adjusted indirect comparison. Methods: Patients from two phase II/III trials for erenumab (NCT02066415 and NCT02456740) were pooled and we...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Becaris Publishing Limited
2024-03-01
|
| Series: | Journal of Comparative Effectiveness Research |
| Subjects: |